Related Experiment Video
Updated: Apr 5, 2026

Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time
Published on: May 20, 2014
Cellular deficiency in the RGS10 protein facilitates chemoresistant ovarian cancer
Shelley B Hooks1, Mandi M Murph1
1Department of Pharmaceutical & Biomedical Sciences, College of Pharmacy, University of Georgia, 240 W Green Street, Athens, GA 30602, USA.
Abstract:
More than 30 regulators of G protein signaling (RGS) proteins encompass the RGS protein superfamily of critical regulators essential to cellular homeostasis. There is enormous structural and functional diversity among the RGS superfamily, and as such they serve a wide range of functions in regulating cell biology and physiology. Recent evidence has suggested roles for multiple RGS proteins in cancer initiation and progression, which has prompted research toward the potential modulation of these proteins as a new approach in cancer therapy. This article will discuss basic RGS molecular pharmacology, summarize the cellular functions and epigenetic regulation of RGS10, review ovarian cancer chemotherapy and describe the role of RGS10 in ovarian cancer survival signaling.
Insights
Regulators of G protein signaling (RGS) proteins are crucial for cell health. This review explores RGS10
Area of Science:
- Molecular pharmacology
- Cellular biology
- Cancer research
Background:
- The RGS protein superfamily comprises over 30 regulators vital for cellular homeostasis.
- RGS proteins exhibit significant structural and functional diversity, impacting various cellular processes.
- Emerging evidence links RGS proteins to cancer initiation and progression, suggesting therapeutic potential.
Purpose of the Study:
- To discuss the molecular pharmacology of RGS proteins.
- To summarize the cellular functions and epigenetic regulation of RGS10.
- To review ovarian cancer chemotherapy and RGS10's role in survival signaling.
Main Methods:
- Literature review of RGS protein functions.
- Analysis of RGS10's role in cellular signaling pathways.
- Examination of RGS10's involvement in ovarian cancer survival.
Main Results:
- RGS proteins are diverse regulators with critical roles in cell biology.
- RGS10 is implicated in ovarian cancer survival signaling pathways.
- Epigenetic regulation of RGS10 influences its function.
Conclusions:
- RGS proteins represent a promising target for novel cancer therapies.
- Understanding RGS10's function is key to developing new ovarian cancer treatments.
- Modulation of RGS proteins offers a potential new avenue for cancer treatment.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
Treatment Resistant Cancers
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

